ANI
24 Jan 2023, 12:07 GMT+10
Hyderabad (Telangana) [India], January 24 (ANI): Granules India announced on Tuesday that the US Food and Drug Administration (US FDA) has approved the abbreviated new drug application (ANDA) filed by its US subsidiary -- Granules Pharmaceuticals, Inc (GPI) -- for Amphetamine mixed salts used for treating attention disorder.
Amphetamine is bioequivalent to the reference listed drug product (RLD), Adderall XR extended-release capsules of Takeda Pharmaceuticals. This product will be manufactured at Granules manufacturing facility in Chantilly, Virginia, and is expected to be launched shortly, according to a company statement shared with stock exchanges.
An abbreviated new drug application (ANDA) is an application for a US generic drug approval for an existing licensed medication or approved drug.
Priyanka Chigurupati, Executive Director, GPI, said "We are pleased to receive the approval of Amphetamine Mixed Salts ER Capsules within 10-months of ANDA filing, which is an extended-release dosage form of a controlled substance (C-II)."Mixed salts of single-entity Amphetamine ER Capsules are indicated for the treatment of attention deficit hyperactivity disorder (ADHD). The company added Granules now have a total of 53 ANDA approvals from US FDA with 51 final approvals and two tentative approvals.
The current annual US market for Amphetamine mixed salts ER capsule product is approximately USD 1.56 billion, according to MAT Nov 2022, IQVIA/IMS Health.
Granules India, incorporated in 1991 is a vertically integrated Indian pharmaceutical company headquartered at Hyderabad with modern facilities. The pharmaceutical company has manufacturing units of the entire value chain - from active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates (PFIs) and finished dosages (FDs).
The company has seven manufacturing facilities out of which six are located in India and one in the US. (ANI)Get a daily dose of Travel Trade news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Travel Trade.
More InformationWASHINGTON, D.C.: A federal rule designed to make it easier for Americans to cancel subscriptions has been blocked by a U.S. appeals...
BASTROP, Texas: In a surprising turn at Elon Musk's X platform, CEO Linda Yaccarino announced she is stepping down, just months after...
NEW YORK CITY, New York: Former British prime minister Rishi Sunak will return to Goldman Sachs in an advisory role, the Wall Street...
LONDON, U.K.: Physically backed gold exchange-traded funds recorded their most significant semi-annual inflow since the first half...
AMSTERDAM, Netherlands: Some 32 percent of global semiconductor production could face climate change-related copper supply disruptions...
NEW YORK, New York - U.S. stocks rebounded Tuesday with all the major indices gaining ground. Markets in the UK, Europe and Canada...
WASHINGTON, D.C.: Travelers at U.S. airports will no longer need to remove their shoes during security screenings, Department of Homeland...
PARIS, France: French military and intelligence officials have accused China of orchestrating a covert campaign to damage the reputation...
PARIS, France: A strike by French air traffic controllers demanding improved working conditions caused significant disruptions during...
WASHINGTON, D.C.: The U.S. government has granted GE Aerospace permission to resume jet engine shipments to China's COMAC, a person...
New Delhi [India], July 12 (ANI): Soon after the Aircraft Accident Investigation Bureau (AAIB) released its preliminary report into...
New Delhi [India], July 12 (ANI): India's Aircraft Accident Investigation Bureau (AAIB) released the preliminary report into the tragic...